TFF PHARMACEUTICALS, INC. Increase (Decrease) in Accrued Liabilities
TFF PHARMACEUTICALS, INC. reported Increase (Decrease) in Accrued Liabilities of $702.90 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was -$169.84K.
- TFF PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was $174.90K.
- TFF PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-03-31 was $697.84K.
- TFF PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2023-12-31 was $371.52K.
- TFF PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $367.09K.
- TFF PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$412.48K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$169.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $5.06K derived: sum of 2 quarters · filed 2024-11-20 | $702.90K 10-Q · filed 2024-11-20 | $1.07M derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-06-30 | $174.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $872.74K 10-Q · filed 2024-08-14 | $1.24M derived: sum of 3 quarters · filed 2024-08-14 | $1.24M derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-03-31 | $697.84K 10-Q · filed 2024-05-14 | $1.07M derived: sum of 2 quarters · filed 2024-05-14 | $1.07M derived: sum of 3 quarters · filed 2024-11-20 | $1.07M derived: sum of 4 quarters · filed 2024-11-20 |
| 2023-12-31 | $371.52K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $371.52K derived: sum of 2 quarters · filed 2024-11-20 | $371.52K derived: sum of 3 quarters · filed 2024-11-20 | $367.09K 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $0.00 derived: sum of 2 quarters · filed 2024-11-20 | -$4.43K 10-Q · filed 2024-11-20 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$4.43K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$4.43K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | -$412.48K 10-K · filed 2024-03-28 |